Skip to content

Post-Extubation Assessment of Clinical Stability in ELBW Infants

Post-Extubation Assessment of Clinical Stability in Extremely Preterm Infants: The PEACE Feasibility Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06037083
Acronym
PEACE
Enrollment
20
Registered
2023-09-14
Start date
2024-10-29
Completion date
2027-04-01
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extremely Low Birth Weight Infants

Keywords

Reintubation, Extubation, Extremely low birth weight infants, Electrical impedance tomography, Cerebral and splanchnic oxygenation, Near infrared spectroscopy, apnea, intermittent hypoxia

Brief summary

This is an observational, proof-of-concept, feasibility study that aims to evaluate the feasibility of a monitoring system that integrates clinical data, high-resolution waveforms from the bedside monitor, regional oxygenation (via cerebral and splanchnic near-infrared spectroscopy), and regional ventilation (via electrical impedance tomography) from 20 extremely low birth weight infants at high-risk of reintubation.

Detailed description

The primary aim of this proof-of-concept study is to evaluate the feasibility and acceptance of a monitoring system that integrates clinical data and biomedical signals from multiple modalities in a cohort of extremely preterm infants at high-risk of clinical instability on non-invasive respiratory support. Secondary aims will be to longitudinally describe peripheral oxygen saturation, cerebral oxygen saturation, splanchnic oxygen saturation and regional lung ventilation in extremely low birth weight infants with or without reintubation during the 7 days post extubation. The application of this multimodal monitoring approach using both clinical and physiological data during the postextubation period will help by making the assessment of clinical stability more comprehensive, more objective, more accurate, more standardized, and more reflective of important end-organ function. Thus, the proposed multimodal monitoring could lead to more informed decisions about reintubation and more individualized treatment plans during this critical period, hence potentially leading to better outcomes.

Interventions

DEVICEOxygen saturation probe

The high-accuracy oxygen saturation signal will be continuously acquired for 168 hours post extubation from a separate pulse oximeter (Radical-7®, Masimo ROOT platform, MasimoCorp, Irvine, LA).

DEVICENear infrared spectroscopy sensors

The cerebral and splanchnic regional oxygen saturation signals will be acquired continuously for 168h post extubation using two near infrared spectroscopy sensors (Masimo ROOT platform, MasimoCorp, Irvine, LA), one placed on the forehead for cerebral oxygenation and one on the abdomen (for splanchnic oxygenation).

DEVICEElectrical impedance tomography

The regional lung ventilation will be measured using Electrical Impedance Tomography (TIMPEL, USA) at three time points: * From 1 hour pre-extubation to 2 hours post extubation (total 3 hours) * Between 24 and 48 hours post extubation (total 3 hours) * Between 72 and 96 hours post extubation (total 3 hours)

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER
St. Justine's Hospital
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 28 Weeks
Healthy volunteers
No

Inclusion criteria

* Birth weight \< 1000g and gestational age \< 28+0 weeks, * Received mechanical ventilation within the first 72h of life, * Undergoing their first planned extubation within the first 6 weeks of life.

Exclusion criteria

\- Congenital anomalies and congenital heart disorders.

Design outcomes

Primary

MeasureTime frameDescription
Recruitment rate168 hoursTo evaluate the time frame needed to recruit patients and percentage of eligible infants recruited
Consent rate168 hoursTo evaluate the percentage of eligible infants consented
Acceptability of the multimodal monitoring approach168 hoursAcceptability of the multimodal monitoring approach will be evaluated using short anonymous surveys distributed to parents, bedside nurses, and attending clinicians participating in the study.

Secondary

MeasureTime frameDescription
To describe longitudinal peripheral blood oxygen saturation patterns for infants with and without reintubation during the 7 days post-extubation168 hoursThe variable will be longitudinally described and graphically displayed using mean (standard deviation), median (interquartile range), or number (percentage) for the hour pre-extubation and for each 24-hour bin post-extubation, and compared between infants requiring reintubation and those not requiring reintubation during the 7 days after extubation.
To describe longitudinal cerebral oxygen saturation patterns for infants with and without reintubation during the 7 days post-extubation168 hoursThe variable will be longitudinally described and graphically displayed using mean (standard deviation), median (interquartile range), or number (percentage) for the hour pre-extubation and for each 24-hour bin post-extubation, and compared between infants requiring reintubation and those not requiring reintubation during the 7 days after extubation.
To describe longitudinal splanchnic oxygen saturation patterns for infants with and without reintubation during the 7 days post-extubation168 hoursThe variable will be longitudinally described and graphically displayed using mean (standard deviation), median (interquartile range), or number (percentage) for the hour pre-extubation and for each 24-hour bin post-extubation. Repeated measures one-way ANOVA or Friedman test will be used to evaluate for differences in the variables over time.
To describe regional lung ventilation from the immediate pre-extubation period until 72-96 hours post-extubation.96 hoursThe variable will be longitudinally described and graphically displayed using mean (standard deviation), median (interquartile range), or number (percentage) for the hour pre-extubation and for each 24-hour bin post-extubation. Repeated measures one-way ANOVA or Friedman test will be used to evaluate for differences in the variables over time.

Countries

Canada

Contacts

CONTACTWissam Shalish, MD, PhD
wissam.shalish@mcgill.ca+1(514) 4124452
PRINCIPAL_INVESTIGATORWissam Shalish, MD, PhD

McGill University Health Center/Montreal Children's hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026